All In MedTech

FDA Clearance Tracker · P130017-S029

Cologuard Stool DNA-Based Colorectal Cancer Screening Test

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 20, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P130017-S029
Device name
Cologuard Stool DNA-Based Colorectal Cancer Screening Test
Applicant location
Medison, WI
Received
Apr 12, 2019
Decided
Sep 20, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P130017

Device type

Device class
Class III

Every decision under product code PHP

FDA's approval statement

As written in FDA's record.

Approval to expand the indicated age range for Cologuard Stool DNA-Based Colorectal Cancer Screening Test from 50 years or older to 45 years or older.

Source documents

Other decisions for Exact Sciences Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.